Our facilities
MCRI stem cell research is supported by in-house state-of-the-art facilities:
- iPSC Derivation and Gene Editing Facility
Our iPSC Derivation and Gene Editing Facility annually services internal and external researchers across the world. - Stem Cell Based Drug Discovery Facility
Our Stem Cell Drug Discovery Facility provides high content screening capacity for 3D organoids, as well as the development of significant expertise in transcriptomics and bioinformatics. - Transcriptomics and Bioinformatics Hub
- Functional Phosphoproteomics Platform
Proudly in partnership with
The Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW, is supported by a Novo Nordisk Foundation grant number NNF21CC0073729